US · 21 CFR
21 CFR Part 1271
Human Cells, Tissues, and Cellular and Tissue-Based Products
eCFR, up to date as of 2026-11-12
Table of contents
- 1271.1What are the purpose and scope of this part?
- 1271.3How does FDA define important terms in this part?
- 1271.10Are my HCT/P's regulated solely under section 361 of the PHS Act and the regulations in this part, and if so what must I do?
- 1271.15Are there any exceptions from the requirements of this part?
- 1271.20If my HCT/P's do not meet the criteria in § 1271.10, and I do not qualify for any of the exceptions in § 1271.15, what regulations apply?
- 1271.21When do I register, submit an HCT/P list, and submit updates?
- 1271.22How do I register and submit an HCT/P list?
- 1271.23How is a waiver from the electronic format requirements requested?
- 1271.25What information is required for establishment registration and HCT/P listing?
- 1271.26When must I amend my establishment registration?
- 1271.27Will FDA assign me a registration number?
- 1271.37Will establishment registrations and HCT/P listings be available for inspection, and how do I request information on registrations and listings?
- 1271.45What requirements does this subpart contain?
- 1271.47What procedures must I establish and maintain?
- 1271.50How do I determine whether a donor is eligible?
- 1271.55What records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain?
- 1271.60What quarantine and other requirements apply before the donor-eligibility determination is complete?
- 1271.65How do I store an HCT/P from a donor determined to be ineligible, and what uses of the HCT/P are not prohibited?
- 1271.75How do I screen a donor?
- 1271.80What are the general requirements for donor testing?
- 1271.85What donor testing is required for different types of cells and tissues?
- 1271.90Are there other exceptions and what labeling requirements apply?
- 1271.145Prevention of the introduction, transmission, or spread of communicable diseases.
- 1271.150Current good tissue practice requirements.
- 1271.155Exemptions and alternatives.
- 1271.160Establishment and maintenance of a quality program.
- 1271.170Personnel.
- 1271.180Procedures.
- 1271.190Facilities.
- 1271.195Environmental control and monitoring.
- 1271.200Equipment.
- 1271.210Supplies and reagents.
- 1271.215Recovery.
- 1271.220Processing and process controls.
- 1271.225Process changes.
- 1271.230Process validation.
- 1271.250Labeling controls.
- 1271.260Storage.
- 1271.265Receipt, predistribution shipment, and distribution of an HCT/P.
- 1271.270Records.
- 1271.290Tracking.
- 1271.320Complaint file.
- 1271.330Applicability.
- 1271.350Reporting.
- 1271.370Labeling.
- 1271.390Applicability.
- 1271.400Inspections.
- 1271.420HCT/Ps offered for import.
- 1271.440Orders of retention, recall, destruction, and cessation of manufacturing.
Cover page and contents (original)
Authority:42 U.S.C. 216, 243, 263a, 264, 271.
Source:66 FR 5466, Jan. 19, 2001, unless otherwise noted.
Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-16